Your browser doesn't support javascript.
loading
Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.
Yao, Hang-Ping; Feng, Liang; Zhou, Jian-Wei; Zhang, Rui-Wen; Wang, Ming-Hai.
Affiliation
  • Yao HP; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital of Zhejiang University School of MedicineHangzhou, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital of Zhejiang University School of
  • Feng L; Cancer Biology Research Center, Texas Tech University Health Sciences Center School of PharmacyAmarillo, TX 79106, USA; Department of Biomedical Sciences, Texas Tech University Health Sciences Center School of PharmacyAmarillo, TX 79106, USA.
  • Zhou JW; Department of Molecular Cell Biology and Toxicology, Nanjing Medical University School of Public Health Nanjing, China.
  • Zhang RW; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy Amarillo, TX 79106, USA.
  • Wang MH; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital of Zhejiang University School of MedicineHangzhou, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital of Zhejiang University School of
Am J Cancer Res ; 6(5): 937-56, 2016.
Article in En | MEDLINE | ID: mdl-27293990
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2016 Type: Article